Table 3 Clearance and persistency rates of HR-HPV infections at the different follow-up intervals with the corresponding Odds ratio and p-values
From: 14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
Follow-up interval (Number of evaluated patients and their types of HR-HPV infection) | Clearance rate (%)a | Persistency rate (%)b | Odds ratio (95% CI) | P-value |
|---|---|---|---|---|
I follow-up (Total Number n = 271) | ||||
HPV mRNA pos/ DNA pos = 110 | n = 112 (41.3%) | n = 159 (58.6%) | 29.2 (13.2–64.6) | < 0.0001 |
HPV mRNA pos /DNA neg = 8 | ||||
HPV mRNA neg/DNA pos = 49 | ||||
HPV mRNA neg/DNA neg = 104 | ||||
II follow-up (Total Number n = 151) | ||||
HPV mRNA pos/ DNA pos = 80 | n = 58 (38.4%) | n = 93 (61.6%) | 3.23 (1.4–7.2) | 0.004 |
HPV mRNA pos /DNA neg = 6 | ||||
HPV mRNA neg/DNA pos = 13 | ||||
HPV mRNA neg/DNA neg = 52 | ||||
III follow-up (Total Number n = 90) | ||||
HPV mRNA pos/ DNA pos = 46 | n = 44 (48.4%) | N = 46 (51.2%) | 10.3 (0.5–197.8) | 0.12 |
HPV mRNA neg/DNA neg = 44 | ||||